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Abstract Interleukin-1 (IL-1) receptor-associated kinases
(IRAKs) are central components of Toll/IL-1 receptor (TIR)
signaling pathways. In an attempt to discover novel signal trans-
ducers in TIR signaling, we identi¢ed human Pellino2 as an
interaction partner of IRAK4. Pellino2 interacts with kinase-
active as well as kinase-inactive IRAK1 and IRAK4. Further-
more, Pellino2 is one of the ¢rst substrates identi¢ed for IRAK1
and IRAK4. Functional studies using overexpression or RNAi
knock-down of Pellino2 suggest a role of Pellino2 as a sca¡old-
ing protein similar to Pellino1. However, unlike Pellino1, Pelli-
no2 does not seem to activate a speci¢c transcription factor, but
links TIR signaling to basic cellular processes.
- 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Toll/interleukin-1 (IL-1) receptor (TIR) family members are
central components of host defense mechanisms in a variety of
vertebrate and invertebrate species [1]. They play a crucial role
in the switch from innate to adaptive immunity in mammals,
either by the recognition of pathogens or as receptors for pro-
in£ammatory cytokines.
The TIR family can be divided into two subfamilies of
transmembrane receptors. The members of one of these sub-
families, which include the IL-1 receptors, have immunoglob-
ulin-like domains in the extracellular portion of the protein.
The other subfamily is represented by the Toll-like receptors,
whose extracellular domain is characterized by leucine-rich
repeats [2]. The unifying structural motif of the TIR family
is the so-called TIR domain in the intracellular domain [3,4].
The ¢rst step in TIR signaling is the ligand-induced forma-
tion of a receptor complex. In mammals, the close proximity
of the TIR domains of the individual receptor chains allows
the recruitment of the adapter molecules MyD88 [5,6] and
Tollip [7]. MyD88 can then, in turn, recruit the IL-1 recep-
tor-associated kinases IRAK1 and IRAK4 [8^11]. This com-
plex interacts with the adapter TRAF6 [12]. The IRAK/
TRAF6 interaction is a key step in the assembly of a multi-
protein signalosome, which includes the mitogen-activated
protein kinase (MAPK) kinase kinase TAK1 [13]. This com-
plex activates a number of downstream signaling cascades,
including IUB kinases, p38 and Jun N-terminal kinases
(JNKs), leading to the activation of transcription factors
such as NF-UB and AP-1 (for review see [1]).
Evolutionarily, the signal transduction mechanisms em-
ployed by TIRs are remarkably conserved [14]. In the fruit
£y Drosophila melanogaster, Toll receptors recruit the adapter
molecule Tube, and the Ser/Thr kinase Pelle, a homolog of
human IRAKs [15]. Yeast two-hybrid screens with Pelle lead
to the identi¢cation of D. melanogaster Pellino, a protein
which can interact with wild-type, but not kinase-inactive
Pelle, although it was not observed to be a substrate of Pelle
[16]. In database searches, two human and murine homologs
of Pellino were identi¢ed and cloned and were found to share
about 60% identity and 75% similarity at the protein level
[17,18]. Very recently, the ¢rst functional characterizations
of human Pellino1 and murine Pellino2 were published
[19,20]. Like their fruit £y counterparts, both proteins are
able to interact with IRAKs, and both were implicated in
IL-1-induced NF-UB activation.
Here we describe the characterization of human Pellino2.
We identi¢ed Pellino2 in a yeast two-hybrid screen with hu-
man IRAK4. h-Pellino2 was found to be e¡ectively phosphor-
ylated by both IRAK1 and IRAK4, and in contrast to results
published for m-Pellino2, h-Pellino2 does not seem to be an
IL-1-speci¢c activator of NF-UB. In contrast, h-Pellino2 could
be a sca¡olding molecule linking TIR signaling to general
cellular processes involved in gene expression.
2. Materials and methods
2.1. Biological reagents and cell culture
The anti-Flag monoclonal antibodies M2, biotinylated M2 (M2-
bio) and M2 cross-linked to Sepharose beads (M2 beads) as well as
Flag peptide were purchased from Sigma-Aldrich. Rabbit anti-myc
polyclonal antibody was purchased from Santa Cruz Biotechnology.
KB cells, 293 cells and the 293 subline 293RI (stably overexpressing
IL-1RI [11]) were maintained in Dulbecco’s modi¢ed Eagle’s medium
supplemented with 10% fetal calf serum. His-tagged recombinant
IRAK4 and IRAK4 KK213AA were expressed in insect cells by using
a Gibco Bac-to-Bac baculovirus expression system, and recombinant
Flag-tagged IRAK1 and IRAK1 K239S were expressed in insect cells
by using the Baculogold system from PharMingen (following the
manufacturer’s recommendations). Synthetic siRNA for Pellino2
(AF302502: AAGGCTATCAGCTGCAAAGGTdTT) and control
siRNA (TTCTCCGAACGTGTCACGTdTT) were purchased from
Xeragon (Qiagen).
2.2. Cloning and expression vectors
Human IRAK4, IRAK4 KK213AA (kinase-inactive mutant) and
IRAK1, IRAK1 K239S (kinase-inactive mutant) have been described
elsewhere [9]. Human Pellino2 cDNA was obtained by polymerase
chain reaction (PCR) with a universal cDNA library as template.
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For mammalian expression, N-terminal Flag-tagged Pellino2 was con-
structed by inserting the PCR-generated cDNA fragment in the mam-
malian expression vector pCMV-Tag2 (Stratagene).
2.3. Yeast two-hybrid screen
Yeast two-hybrid screens were performed using the Matchmaker
GAL4 Two Hybrid System 3 (yeast host strain AH109; Clontech)
and the human HeLa Matchmaker cDNA Library (Clontech) follow-
ing the manufacturer’s recommendations. Human IRAK4 was cloned
into the pGBKT7 vector. Plasmid DNA from positive yeast clones
was prepared by chloroform extraction and afterwards ampli¢ed in
Escherichia coli for subsequent DNA sequencing.
2.4. Immunoprecipitations of overexpressed proteins and
immunoblotting
For co-precipitation of overexpressed proteins, 5U106 293 cells
were plated on 10 cm dishes and transfected on the following day
with Lipofectamine2000 reagent (Invitrogen). Lysis (250 mM NaCl,
10 mM HEPES pH 7.9, 20 mM L-glycerophosphate, 1 mM sodium
orthovanadate, 1 mM EDTA, 5 mM p-nitrophenyl phosphate, 1 mM
dithiothreitol, protease inhibitors (Complete, Roche Molecular Bio-
chemicals), 0.1% NP-40 and 10% glycerol) and immunoprecipitation
were performed as described elsewhere [21].
2.5. In vitro kinase assays
N-terminal Flag-tagged Pellino2 was overexpressed in 293 cells and
immunoprecipitated with M2 beads. Pellino2 was eluted from the
beads with Flag peptide and incubated with 100 ng of recombinant
kinases in 20 Wl kinase bu¡er (20 mM Tris pH 7.6, 1 mM dithiothrei-
tol, 20 mM MgCl2, 20 mM L-glycerophosphate, 20 mM p-nitrophenyl
phosphate, 1 mM EDTA, 1 mM sodium orthovanadate, protease
inhibitors (Complete, Roche Molecular Biochemicals), 20 WM ATP)
with 10 WCi Q[32P]ATP (NEN) for 20 min at 30‡C. The kinase reaction
was stopped by boiling in 20 Wl 2USDS sample bu¡er. Proteins were
separated via SDS^PAGE, and gels were dried and exposed to X-ray
¢lm.
2.6. Reporter assays
1U105 cells were seeded into 24 well plates. For experiments with
the NF-UB-dependent ELAM promoter and the Jun/Fos-dependent
AP-1 promoter, cells were transfected on the following day using
Lipofectamine2000 (Invitrogen) with 0.01 Wg p-37tkRL (Renilla lucif-
erase gene under the control of the truncated HSV-TK promoter from
position 337 to +52 [22]) and 0.1 Wg pELAM-luc (3UNFUB binding
sites [23]) or pAP-1-luc (4UAP-1 binding sites in front of a truncated
HSV-TK promoter from 350 to +10) and 0.24 Wg of expression con-
structs and 0.45 Wg siRNA to a total of 0.8 Wg DNA/RNA per trans-
fection. After 48 h, the cells were harvested and Renilla and ¢re£y
luciferase activity was determined with the Dual-Luciferase Assay
System (Promega). The PathDetect trans-reporting systems (Strata-
gene) were used according to the manufacturer’s protocol. Cells
were harvested 24 h after transfection and Renilla and ¢re£y luciferase
activity was determined with the Dual-Luciferase Assay System
(Promega).
3. Results
3.1. Interaction of Pellino2 with IRAKs
In an attempt to identify novel proteins involved in TIR
signaling, we performed yeast two-hybrid screens with full
length IRAK4 as bait and a HeLa cDNA library as target.
Three yeast clones speci¢cally interacted with IRAK4 under
high stringency conditions. Two of these three clones encoded
proteins known to interact with IRAK4 (MyD88 and
IRAK1), while the third one encoded the N-terminus (the ¢rst
167 of 420 amino acids) of Pellino2.
We isolated full length Pellino2 from a universal cDNA
library via PCR, and veri¢ed the interaction with IRAK1
and IRAK4 in mammalian cells. For this purpose, we co-ex-
pressed Flag-tagged Pellino2 and myc-tagged IRAKs in 293
cells, immunoprecipitated Pellino2 and analyzed the immuno-
precipitates for co-precipitating IRAKs (Fig. 1). Pellino2 is
able to interact with both IRAK1 and IRAK4 independently
of their kinase activities (IRAK1 K239S and IRAK4
KK213AA have point mutations in their ATP binding pock-
ets, which abolish their kinase activities, Fig. 1A). At least
under overexpression conditions in 293 cells, the interaction
between Pellino2 and IRAK1 is signi¢cantly stronger than the
interaction with IRAK4 (the left panel of Fig. 1A,C is from a
longer exposure, the right panel from a shorter exposure of
one Western blot). Western blots from cell lysates, which co-
express Pellino2 with IRAK1, reveal two bands in the Pellino2
Western blot (Fig. 1D), suggesting an IRAK1-induced mod-
i¢cation of Pellino2 resulting in a second Pellino2 species with
Fig. 1. IRAK1 and IRAK4 co-immunoprecipitate with Pellino2 in
293 cells. 293 cells were co-transfected with N-terminal myc-tagged
IRAK4 (wt, kinase-active), IRAK4 KK213AA (KA, kinase-inactive
mutant), IRAK1 (wt, kinase-active), IRAK1 K239S (KS, kinase-in-
active mutant) and empty vector or N-terminal terminal Flag-tagged
Pellino2. After anti-Flag immunoprecipitation of Pellino2, co-precip-
itating IRAKs were identi¢ed by anti-myc Western blot (A). Anti-
Flag Western blot showed immunoprecipitated Pellino2 (B). Western
blots of whole cell lysates with anti-myc antibody (C) and anti-Flag
antibody (D) veri¢ed IRAK and Pellino2 expression.
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a reduced electrophoretic mobility. This modi¢cation depends
on the kinase activity of IRAK1 and cannot be achieved by
co-expression of IRAK4 and Pellino2. This second Pellino2
species cannot be immunoprecipitated via the N-terminal Flag
tag (Fig. 1B). The exact nature of the modi¢cation(s) leading
to this dramatic shift in electrophoretic mobility is unknown.
Both Pellino2 and IRAK1 have decreased expression levels
when co-expressed, compared to expression alone or expres-
sion with IRAK4, and the number of high molecular weight
species for IRAK1 is increasing, suggesting increased ubiqui-
tinylation and subsequent degradation of IRAK1 [24] (Fig.
1C,D).
3.2. Pellino2 phosphorylation by IRAKs
We performed in vitro kinase assays with recombinant Pel-
lino2 puri¢ed from 293 cells and IRAKs puri¢ed from insect
cells. The Pellino2 preparation as well as preparations of ki-
nase-inactive IRAK4 and IRAK1 did not contain any detect-
able kinase activity, while kinase-active IRAK4 and IRAK1
were clearly detectable by their autophosphorylation (Fig. 2A,
left side). When Pellino2 was mixed with IRAKs, both
IRAK4 and IRAK1 were able to e⁄ciently phosphorylate
Pellino2 (Fig. 2A, right side). Phosphorylation of Pellino2
by IRAK1 produced two distinct phosphoproteins, presum-
ably hypo- and hyperphosphorylated Pellino2. This pattern is
similar to that observed in co-expression experiments in 293
cells (Fig. 1D), although under the in vitro conditions only a
small fraction of the Pellino2 could have been converted into
the hyperphosphorylated form, because it was not detectable
by Western blot (Fig. 2B). In addition, the extent of the re-
duction in electrophoretic mobility of Pellino2 observed in this
in vitro phosphorylation assay is much smaller than that ob-
served in the co-immunoprecipitation experiment (Fig. 2),
suggesting that the Pellino2 modi¢cation induced by co-ex-
pression with IRAK1 is not caused exclusively by phosphor-
ylation. Despite the fact that under co-expression conditions
the interaction between Pellino2 and IRAK4 seems to be
weaker than the Pellino2/IRAK1 interaction (Fig. 1A), the
Pellino2 phosphorylation by IRAK4 is at least as strong as
the phosphorylation by IRAK1.
3.3. Functional characterization of Pellino2
Based on the observation that Pellino2 interacts with and is
phosphorylated by IRAKs, we started to study the e¡ects of
Pellino2 overexpression or downregulation by RNAi [25] in
the context of IL-1 signaling. When we overexpressed Pellino2
in 293RI cells, we were unable to detect any reproducible
e¡ects (positive or negative) on IL-1-induced NF-UB activa-
tion (reporter assays and electrophoretic mobility shift assay
(EMSA)), JNK or Erk activation (in vitro kinase assays, anti-
phospho Western blotting, trans-reporter assays) or AP-1 ac-
tivation (EMSA, reporter assays). Similarly, downregulation
of endogenous Pellino2 by about 80% (determined by Taq-
man qPCR, data not shown) in a RNAi approach did not
have any signi¢cant e¡ects on IL-1-induced cytokine produc-
tion in 293RI and KB cells (IL-6 and IL-8, both enzyme-
linked immunosorbent assay). Furthermore, both basal and
IL-1-induced NF-UB activation (EMSA, reporter assay)
were not a¡ected in 293RI cells (data not shown).
The only e¡ect we observed consistently was a Pellino2
overexpression-induced, increased luciferase reporter activity
in 293RI cells (Fig. 3). Qualitatively, this increase in luciferase
reporter activity was independent of the luciferase gene (Fig.
3A: Renilla, Fig. 3B: ¢re£y luciferase) and independent of
speci¢c transcription factor binding sites in the promoter. In
fact, the e¡ects observed with a basic TATA box promoter
from the HSV-TK promoter (Fig. 3A) were very similar to
e¡ects observed with AP-1/TK-driven promoters (Fig. 3B).
Additionally, Pellino2 overexpression-induced activation of
an AP-1/TK reporter construct could also be observed in mu-
rine embryonic ¢broblast lines, although we could not detect
any increased AP-1 DNA binding activity by EMSA (data not
shown).
While reporter constructs with a basic promoter from HSV-
TK responded strongly to Pellino2 overexpression (Fig.
3A,B), basic promoters derived from the adenoviral E1B
gene responded moderately (Fig. 3D, here fused with a Gal4
binding site), whereas a promoter derived from the human
ELAM gene did not respond signi¢cantly (Fig. 3E).
The Pellino2-induced, increased reporter activity could be
completely reversed by Pellino2-speci¢c siRNAs, suggesting
that these e¡ects are not general overexpression artifacts,
but speci¢c for Pellino2 activity (Fig. 3A^C).
4. Discussion
Here we report the characterization of human Pellino2,
which we identi¢ed via its ability to interact with human
IRAK4 in a yeast two-hybrid system. The ¢rst Pellino protein
was identi¢ed in D. melanogaster as an interaction partner of
Fig. 2. Recombinant, kinase-active IRAK1 and IRAK4 phosphory-
late Pellino2 in vitro. The in vitro kinase reaction was performed
with 100 ng recombinant IRAK4 (I4-wt, kinase-active), IRAK4
KK213AA (I4-KA, kinase-inactive mutant), IRAK1 (I1-wt, kinase-
active) or IRAK1 K239S (I1-KS, kinase-inactive mutant) expressed
in insect cells and Pellino2 expressed in mammalian cells in the pres-
ence of 20 WM ATP and 10 WCi Q[32P]ATP per reaction (A) or cold
ATP only (B). The autoradiograph in A shows the autophosphory-
lation of the kinase-active IRAKs as well as the phosphorylation of
Pellino2, whereas the anti-Flag Western blot of the non-radioactive
in vitro kinase reaction shows equal amounts of Pellino2 per sample
(B).
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the Ser/Thr kinase Pelle [16]. Two homologs were described in
man and mouse [17]. Similar to D. melanogaster Pellino, hu-
man Pellino1 and murine Pellino2, the human Pellino2 is able
to interact physically with Ser/Thr kinases of the Pelle/IRAK
family [19,20]. In contrast to dm-Pellino, h-Pellino2 can inter-
act with IRAK1 and IRAK4 independently of their kinase
activity, and most importantly, h-Pellino2 is one of the ¢rst
kinase substrates identi¢ed for IRAK1 and IRAK4.
For Pellino1, a model was proposed in which Pellino1
serves as a sca¡olding protein in an intermediate complex at
the plasma membrane, allowing IRAKs and TRAF6 to leave
the IL-1 receptor (complex I) and to interact with the TAK1/
TAB1/TAB2 complex (complex II) [19]. It can be speculated
that Pellino2 serves a similar function. This speculation is
supported by the observation that co-expression of Pellino2
and kinase-active IRAK1 results in a high molecular weight
species of Pellino2, which cannot be immunoprecipitated
under standard conditions, indicating either a dramatic con-
formational change or change in the subcellular location of
Pellino2, e.g. into membrane rafts. The phosphorylation of
Pellino2 by activated IRAK1 and IRAK4 could trigger and
modulate the translocation of IRAKs from complex I to com-
plex II.
Both Pellino2 and IRAK1 show a decreased expression
level when co-expressed in 293 cells. The IRAK1 Western
blot indicates an increase in high molecular weight species
(Fig. 1C), suggesting increased ubiquitinylation and degrada-
tion of IRAK1 [24]). However, we did not observe any e¡ects
of the Pellino2/IRAK interaction on the kinase activity of
IRAKs in vitro when these assays were performed with re-
combinant proteins, which suggests that Pellino2 is not a di-
rect modulator of IRAK1’s or IRAK4’s kinase activity, at
least under these experimental conditions.
The experimental evidence linking Pellino proteins to TIR
signaling in Drosophila, mice and man is very strong. Their
ability to interact with Pelle/IRAKs, and the lack of any do-
main capable of enzymatic activity, makes a function as scaf-
fold or adapter protein very likely. Nevertheless, the biologi-
cal e¡ects of this sca¡olding or adapter function are less clear.
Human Pellino1 was shown to be speci¢cally involved in IL-1-
induced NF-UB activation in human 293 cells: increased levels
of Pellino1 (overexpression) lead to an increase in basal NF-
UB activation, while a decrease in Pellino1 expression (RNAi)
leads to a decrease in IL-1-induced NF-UB activation [19]. On
the other hand, murine Pellino2 overexpression was shown
not to have any e¡ect on basal, IL-1- or lipopolysaccharide
(LPS)-induced reporter gene activation, although reduction of
m-Pellino2 expression levels in an antisense approach leads to
a decrease in IL-1- and LPS-induced IL-8 reporter gene activ-
ity in a murine embryonic ¢broblast cell line [20].
Fig. 3. Pellino2 overexpression enhances luciferase reporter activity. A^C: 293RI cells were transfected in triplicate with vectors encoding Renil-
la luciferase under the control of the truncated HSV-TK promoter and ¢re£y luciferase under the control of 4UAP-1/TK promoter together
with increasing amounts of Flag-tagged Pellino2 as well as unspeci¢c (ctrl siRNA) or Pellino2-speci¢c siRNA (peli2 siRNA). Cells were har-
vested 48 h after transfection and the activities measured for Renilla luciferase (A) and ¢re£y luciferase (B). Expression of Pellino2 and its re-
duction due to the Pellino2-speci¢c siRNA was veri¢ed by anti-Flag Western blotting of cell lysates (C). D: Cells were transfected in triplicate
with ¢re£y luciferase under the control of GAL4/E1B promoter and pFA2-CREB fusion trans-activator plasmid and increasing amounts of
Flag-tagged Pellino2. Cells were harvested 24 h after transfection and the Renilla and ¢re£y activities were measured. E: Cells were transfected
and harvested as in B, but with a ¢re£y luciferase construct under the control of a truncated ELAM promoter.
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Theoretically the di¡erent observations obtained in pub-
lished studies of h-Pellino1 or m-Pellino2 as well as our ob-
servations regarding h-Pellino2 could be explained by species-
and cell type-speci¢c functions of Pellino molecules. Especially
comparing Pellino1 and Pellino2, completely redundant func-
tions are unlikely, despite their 81% identity and 90% homol-
ogy. The observed di¡erences between human and murine
Pellino2 are more di⁄cult to explain, and might be more a
result of di¡erent experimental procedures than of di¡erent
biological functions.
In our hands, the suppression of endogenous Pellino2 levels
by 80% in human 293 and KB cells does not have any sig-
ni¢cant e¡ects on IL-1-induced IL-8 production or reporter
gene activation. In addition, we cannot observe any reprodu-
cible e¡ects of h-Pellino2 overexpression on MAPK activa-
tion. But Pellino2 overexpression was found to consistently
and reproducibly increase the luciferase activity in most re-
porter assays, independently of the speci¢c luciferase gene or
speci¢c transcription factor binding sites, and without increas-
ing the DNA binding activity of the transcriptions factors
AP-1 and NF-UB. The activation of luciferase activity de-
pended more on the basic promoter used for a particular lu-
ciferase construct than on the regulatory elements of this pro-
moter, although the extent of the activation was, of course,
not completely independent of speci¢c transcription factor
binding sites. This hints towards a more general role of
Pellino2. The high degree of evolutionary conservation of
Pellino molecules from di¡erent species (h-Pellino2 is 60%
identical and 75% similar to dm-Pellino) also makes a highly
specialized function unlikely [17,18]. Based on the observed
lack of any speci¢c e¡ect of h-Pellino2 on tumor necrosis
factor- or IL-1-mediated signaling pathways, Pellino2 is
most likely not responsible for the IL-1-induced activation
of a certain transcription factor, but links TIR signaling to
general cellular functions, like the transcription machinery.
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